Bring patients enrolled in clinical trials into the lab by developing new organoid models
Gauge the efficacy of your drug by simulating clinical trials in organoids
Prioritise participant enrollment by identifying responders and non-responders in prospective trials
Delve into the underlying mechanism of response or non-response and discover novel biomarkers
PUBLICATION